Fig. 2From: Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trialImages in T2, b2000 and PSMA-PET (PSMA-PET/CT registered to T2) images showing a GTV in the right peripheral zone of a patient planned for fBTBack to article page